We confirmed an increased level of plasma cells in diffuse versus intestinal tumors using IRF4 (a plasma cell marker) IHC on a subset of tumors (n = 17, P = 0.036; Fig. 3B; Supplementary Fig. S5B). Here, IRF4 is linked to intestinal neoplasm.